Helix mimetics as inhibitors of the interaction of the estrogen receptor with coactivator peptides.

Helix mimetics as inhibitors of the interaction of the estrogen receptor with coactivator peptides. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Helix mimetics as inhibitors of the interaction of the estrogen receptor with coactivator peptides. Abstract Text:

Jorge Becerril,Andrew D Hamilton,

Helix mimetics as inhibitors of the interaction of the estrogen receptor with coactivator peptides. Publishing Authors By Initials

J Becerril,AD Hamilton,

For similar biochemical phenomena, metabolism, and nutrition: biochemical phenomena: structure-activity relationship research abstracts see: biochemical phenomena, metabolism, and nutrition: biochemical phenomena: structure-activity relationship research

PUBMED ID PMID:

MEDLINE DATE:

Helix mimetics as inhibitors of the interaction of the estrogen receptor with coactivator peptides. Journal Published:

PUBLICATION TYPE: Research Support, N.I.H., Extr

Journal: Angewandte Chemie (International ed. in English)

VOLUME: 46

Page Numbers: 4471-3

Journal Abbreviation: Angew. Chem. Int. Ed. Engl.

ISSN: 1433-7851

DAY: 3

MONTH: 12

YEAR: 2007

Helix mimetics as inhibitors of the interaction of the estrogen receptor with coactivator peptides. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 370543

Helix mimetics as inhibitors of the interaction of the estrogen receptor with coactivator peptides. Keywords Mesh Terms:

KEYWORDS: Structure-Activity Relationship

MESH TERMS: metabolism

Chemical & Substance for Abstract: Helix mimetics as inhibitors of the interaction of the estrogen receptor with coactivator peptides. Information

Substance Name: Receptors, Estrogen

Registry Number: 0

Grant and Affiliation Information for Helix mimetics as inhibitors of the interaction of the estrogen receptor with coactivator peptides.

AFFILIATION: Department of Chemistry, Yale University, P. O. Box 208107, New Haven, CT 06520-8107, USA.

Country: Germany

AGENCY: United States NIGMS

GRANT: GM69850

ACRONYM: GM

MEDLINETA: Angew Chem Int Ed Engl

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Helix mimetics as inhibitors of the interaction of the estrogen receptor with coactivator peptides Related Publications

• 'Physical Inactivity' (Low NEAT) is NOT the Same Physiologically as the 'Lack of Exercise'?: 342: 1:05 PM -1:15 PM.
• Analysis of association between the serotonin transporter and antidepressant response in a large clinical sample.
• Are Chemical (Lipase Dependent) Signals Sufficient to Mimic Exercise-Induced Endothelial Phenotypes?: 67: 1:35 PM-2:00 PM.
• Arsenic disruption of steroid receptor gene activation: Complex dose-response effects are shared by several steroid receptors.
• Associations of Ki-ras proto-oncogene mutation and p53 gene overexpression in sporadic colorectal adenomas with demographic and clinicopathologic characteristics.
• Automated Quantification of Lymph Node Size and Number in Surgical Specimens of Stage II Colorectal Cancer.
• Developing clinical standards and accrediting clinics in infertility care.
• Diphenylindane-based proteomimetics reproduce the projection of the i, i+3, i+4, and i+7 residues on an alpha-helix.
• Effects of eccentric contractions on skeletal muscle function in a malignant hyperthermia mouse model: 2352: board #31 june 1 2:00 PM -3:30 PM.
• Fibroblast growth factor causes an early increase in phosphorylation of a membrane protein in quiescent 3T3 cells.
• Gene-lifecourse interaction for alcohol consumption in adolescence and young adulthood: five monoamine genes.
• Helix mimetics as inhibitors of the interaction of the estrogen receptor with coactivator peptides.
• Identification of atherosclerotic lipid deposits by diffusion-weighted imaging.
• Identification of cysteines involved in S-nitrosylation, S-glutathionylation, and oxidation to disulfides in ryanodine receptor type 1.
• Introduction and Overview: 341: 1:00 PM-1:05 PM.
• Introduction and Overview: 65: 1:00 PM-1:10 PM.
• Modifications of the GSK3beta substrate sequence to produce substrate-mimetic inhibitors of Akt as potential anti-cancer therapeutics.
• Nonlinear surface waves in soft, weakly compressible elastic media.
• Prize-based contingency management does not increase gambling.
• Protein-protein interaction inhibitors: small molecules from screening techniques.
• Recognition of solvent exposed protein surfaces using anthracene derived receptors.
• Shifts in thioredoxin reductase activity and oxidant status in mononuclear cells obtained from transition dairy cattle.
• Signaling in lipopolysaccharide-induced stabilization of formyl peptide receptor 1 mRNA in mouse peritoneal macrophages.
• Sociology-the poor relation in alcohol and drug research?
• Sonotubometry.
• Structure-activity studies on a library of potent calix[4]arene-based PDGF antagonists that inhibit PDGF-stimulated PDGFR tyrosine phosphorylation.
• Synthesis and evaluation of potent, highly-selective, 3-aryl-piperazinone inhibitors of protein geranylgeranyltransferase-I.
• Synthetic non-peptide mimetics of alpha-helices.
• Two lyophilized polymer matrix recombinant human bone morphogenetic protein-2 carriers in rabbit calvarial defects.
• Zfp423 controls proliferation and differentiation of neural precursors in cerebellar vermis formation.